다낭성난소증후군 치료의 최신지견

참고문헌 (45)

1. Stein IF, "Amenorrhoea associated with bilateral polycystic ovaries", 29, pp.181~91 (1935)
2. Barbieri RL, "The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism", 50, pp.197~212 (1988)
3. Franks S, "Polycystic ovary syndrome:a changing perspective", 31, pp.87~120 (1989)
4. Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
5. Yildiz BO, "and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome", 88, pp.2031~6 (2003)
6. Nixon C, "Prevalence of polycystic ovary syndrome in first-degree relatives of patients with PCOS", 75, pp.53~8 (2001)
7. Legro RS, "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome controlled study in 254 affected women", 84, pp.165~9 (1999)
8. Weerakiet S, "Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome", 75, pp.177~84 (2001)
9. Norman RJ, "Hyperinsulinemia is common in family members of women with polycystic ovary syndrome", 66(6), pp.942~7 (1996)
10. Pouliot MC, "best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women", pp.460~8
11. Kiddy DS, "Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome", 36, pp.105~11 (1992)
12. Huber-Buchholz MM, "Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome:role of insulin sensitivity and luteinizing hormone", 84, pp.1470~4 (1999)
13. Nestler JE, "Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome" (1876)
14. Velazquez E, "Menstrual cyclicity after metformin therapy in polycystic ovary syndrome", 90, pp.392~5 (1997)
15. Ehrmann DA, "Effects of metformin on insulin secretion and ovarian steroidogenesis in women with polycystic ovary syndrome", 82, pp.524~30 (1997)
16. Nestler JE, "Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome", 77, pp.209~15 (2002)
17. Nestler JE, "Insulin as an effector of human ovarian and adrenal steroid metabolism", 20, pp.807~23 (1991)
18. Kashyap S, "Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome", 19, pp.2474~83 (2004)
19. DeLeo V, "Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome", 72, pp.282~5 (1999)
20. Attia GR, "Metformin directly inhibits androgen production in human thecal cells", 76, pp.517~24 (2001)
21. Coetzee EJ, "Metformin in management of pregnant insulin-independent diabetics", 16, pp.241~5 (1979)
22. Vanky E, "Placental passage of metformin in women with polycystic ovary syndrome", 83(5), pp.1575~8 (2005)
23. Dunaif A, "The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome", 81, pp.3299~306 (1996)
24. Mitwally MF, "High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome", 14, pp.2700~3 (1999)
25. Ehrmann D, "Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome", 86(4), pp.1626~32 (2001), a multicenter
26. Tafuri SR, "and Glut1 protein levels in 3T3-L1 adipocytes", 137, pp.4706~12 (1996)
27. Kim CH, "Effects of rosiglitazone on ovarian stromal blood flow ovarian stimulation and outcome in patients with polycystic ovary syndrome undergoing in vitro fertilization", 18, pp.172~ (2003)
28. Belli SH, "Effect of rosiglitazone on insulin resistance and reproductive disturbances in women with polycystic ovary syndrome", 81(3), pp.624~9 (2004)
29. 이향아, "다낭성난소증후군 환자에서 pioglitazone이 인슐린 민감도, 난소 기능, 난소 기질 내 혈류에 미치는 영향", Clinical and Experimental Reproductive Medicine, 32(2), pp.155~164 (2005), 대한생식의학회
30. Fulghesu AM, "N-Acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome", 77(6), pp.1128~35 (2002)
31. Rizk AY, "N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome", 83, pp.367~70 (2005)
32. Nestler JE, "Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome", 340, pp.1314~20 (1999)
33. Mitwally MF, "Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate", 75(2), pp.305~9 (2001)
34. Al-Omari WR, "Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome", 85(3), pp.289~91 (2004)
35. 김정훈, "다낭성난소증후군 환자들에서 배란유도시 성장억제 호르몬 유사체가 난소반응에 미치는 영향", 42, pp.496~503 (1999)
36. 이종표, "다낭성난소증후군 환자들에서 배란유도시 성장억제호르몬 유사체의 전처치가 난소 반응에 미치는 영향", 43, pp.423~30 (2000)
37. Kolibianakis EM, "Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotrophin releasing hormone antagonist cycles is associated with a reduced chance of pregnancy", 79, pp.873~90 (2003)
38. Craft I, "Will GnRH antagonists provide new hope for patients considered", 14, pp.2959~62 (1999)
39. Bracero N, "patients have a favorable response to ganirelix acetate during controlled ovarian hyperstimulation for in vitro fertilization", 78, pp.3~50 (2002)
40. Elkind-Hirsch KE, "Concurrent Antagon and Follistim therapy for ovulation induction in women with polycystic ovary syndrome", 79, pp.603~7 (2003)
41. Hwang JL, "Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre- treatment for patients with polycystic ovary syndrome:a prospective randomized study", 19, pp.1993~2000 (2004)
42. 최정원，김정훈，이향아，홍석호，나희영，이영진 등, "체외수정시술을 받는 다낭성난소증후군 환자들에서 GnRH antagonist를 이용한 과배란유도의 효용성", 48(3), pp.716~25 (2005)
43. Karbowiak I, "In-vivo metabolites of spironolactone and potassium canrenoate determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay", 23(l), pp.341~7 (1985)
44. Heiner JS, "Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism", 80, pp.3412~8 (1995)
45. Azziz R, "Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism:a prospective randomized study", 80, pp.3406~11 (1995)

관련 논문AI추천